Related Experiment Video
Updated: Apr 25, 2026

Next Generation Sequencing for the Detection of Actionable Mutations in Solid and Liquid Tumors
Published on: September 20, 2016
ALK-Positive Lung Adenocarcinoma With Suspected Transformation to Squamous Cell Carcinoma in Lymph Node Metastases
Yusuke Okamoto1, Naofumi Miyahara1, Keita Kai2
1Department of General Thoracic and Cardiovascular Surgery, Faculty of Medicine, University of Saga, Saga, Japan.
Abstract:
The development of resistance to anaplastic lymphoma kinase (ALK) inhibitors appears to be inevitable in the treatment of non-small cell lung cancer because of several mechanisms. We report the case of resected lung adenocarcinoma with mediastinal lymph node metastasis that underwent histologic transformation to ALK-rearranged squamous cell carcinoma without prior exposure to ALK inhibition.
Insights
Resistance to anaplastic lymphoma kinase (ALK) inhibitors is common in non-small cell lung cancer. This case shows a rare transformation to ALK-rearranged squamous cell carcinoma without prior ALK inhibitor exposure.
Area of Science:
- Oncology
- Molecular Biology
- Pathology
Background:
- Anaplastic lymphoma kinase (ALK) inhibitors are crucial in treating ALK-positive non-small cell lung cancer.
- Mechanisms of resistance to ALK inhibitors are well-documented.
- Histologic transformation is a known, albeit less common, resistance mechanism.
Related Concept Videos
Cellular Adaptation IV: Dysplasia and Metaplasia
Metastasis
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...

